Buyout Desk
Strategic

Rockwell Medical to acquire most of Vantive's hemodialysis assets

Rockwell Medical agrees to buy Vantive's hemodialysis concentrates, machines and water treatment business, with a Medolla, Italy campus, targeting $400 million to $450 million combined annual revenue.

Wixom, Michigan-based Rockwell Medical (Nasdaq: RMTI) has entered into an Equity and Asset Purchase Agreement with Vantive Limited to acquire Vantive's hemodialysis concentrates, HD machines including AK-98, water treatment systems, and related consumables and technical services business. Closing is expected in mid-2027, subject to regulatory approvals and other customary conditions. Vantive retains its dialyzer portfolio, including Theranova.

The base price is $125 million, subject to adjustments, plus up to $45 million contingent on revenue and EBITDA milestones. Vantive will finance the base payment with two $50 million term loans and a $25 million convertible note.

Rockwell Medical will also acquire Vantive's one million square foot manufacturing campus in Medolla, Italy, within the Mirandola Biomedical District. The campus makes dry concentrate cartridges, HD machines, parts, consumables and water treatment systems. Rockwell estimates the combined business could generate annual revenue of $400 million to $450 million, subject to operational, currency and market assumptions.

Deal facts

Target
Most of Vantive's hemodialysis assets
Business
Vantive's hemodialysis concentrates, HD machines, water treatment systems, consumables and technical services business, plus its Medolla, Italy manufacturing campus
Buyer
Rockwell Medical
Seller
Vantive Limited
Deal type
Strategic
Value
$125 million base
Advisers
  • Perella Weinberg Partners LP financial adviser to Vantive
  • Barclays financial adviser to Vantive
  • Kirkland & Ellis LLP legal counsel to Vantive
  • Aquilo Partners, L.P. financial adviser to Rockwell Medical
  • Gibson Dunn & Crutcher LLP legal counsel to Rockwell Medical
Status
Announced
Announced
Tuesday, November 3, 2026

Sources

Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.